Sutro Biopharma (STRO) financials · rev $102.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Sutro Biopharma (STRO) rev $102.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $102.5M | $62.0M |
| Operating Income | -$158.4M | -$238.5M |
| Net Income | -$191.1M | -$227.5M |
| EPS (Diluted) | -$22.49 | -$2.96 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $173.8M | $387.2M |
| Current Assets | $150.9M | $343.3M |
| Cash & Equivalents | $58.1M | $190.3M |
| PP&E | $10.6M | $18.2M |
| Total Liabilities | $306.3M | $342.6M |
| Current Liabilities | $75.1M | $131.9M |
| Shareholders' Equity | -$132.5M | $44.6M |
| Retained Earnings | -$978.0M | -$786.9M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$177.2M | -$191.5M |
| Investing Cash Flow | $45.0M | $218.5M |
| Financing Cash Flow | $44.0K | $94.1M |
| Net Change in Cash | -$132.2M | $121.0M |
FAQ
What is STRO P/E and revenue?
Sutro Biopharma (STRO) rev $102.5M.
What is STRO revenue?
Sutro Biopharma last cached revenue is $102.5M (FY2025).
Is STRO profitable?
Sutro Biopharma last cached net income is -$191.1M (FY2025).
What are STRO total assets?
Sutro Biopharma last cached total assets are $173.8M (FY2025).
What is STRO free cash flow?
No cached cash-flow row for STRO yet.
Not investment advice. Cached statements, not a live tape.